• Breaking News

    Wednesday, November 30, 2016

    Is this the end of deadly HIV/Aids virus? The trial treatment is kick-starting in South Africa

    HIV is a virus that has claimed millions of lives since the outbreak in the early 80s, and ever since then, efforts have been made by health organisations but no successful results have been able to be reached.

    This is time there are possibilities the newly discovered vaccine will be able to put an end to HIV killings.

    The virus HIV causes Aids which eventually kills after developing.

    The virus outbreak has claimed over 30 million lives UN has said.

    The newly detected vaccine is going to kick start its treatment in South Africa and will enrol 5,400 sexually active young men and women to be able effective result according to medical team responsible for the project. 
    One of the reasons the treatment is kick starting in South Africa, is the fact that over seven million people are leaving with deadly HIV/Aids virus in the African Nation. 

    Health experts hope the vaccine will be "the final nail in the coffin" for HIV, the recent vaccine is code-named HVTN702.

    In 2009 an HIV vaccine was tested in Thailand and the effect of it was 30% but this time there is possibilities, it will be final for the deadly virus to be defeated.

    Dr Glenda Gray, who is the leader of the medical team on the test is a university research professor and head of South Africa's Medical Research Council said: "It will tell us whether the initial success observed [at a smaller scale] will bear fruit in the form of a safe and effective HIV vaccine designed for the people of southern Africa," Dr Gray said.

    The previous vaccine that have been discovered by health researchers, has been able to increase the life-span of patients while doctors best advice for those who wish to have sexual intercourse, is to go for protected s*x or better still abstain from it.

    The process of the trial process, the study participants will receive a total of five injections over one year, says the US National Institutes of Health (NIH), the sponsorer of the project.

    A 20-year-old construction worker, Awethu Benenengu, is one of the participants in the trial, told the BBC's Nomsa Maseko in Johannesburg that he volunteered because he wanted to help defeat Aids.

    "I decided to get involved because I don't like the way my HIV-positive cousin is treated," Mr Benenengu said.

    "There is so much stigma. I want to be part of a generation that changes this and I want my children to be proud one day of their father for getting involved in making history."

    If any of the participants got infected by the virus (HIV) during the trial of the treatment, they will be taken care off by the NIH through the local medical providers for care and treatment as well as educating them on what to do in order not to infect people with the virus.

    No comments:

    Post a Comment

    Fashion

    Beauty

    Culture